15 results on '"Onuma, Oyere"'
Search Results
2. Stroke: a global response is needed.
- Author
-
Johnson, Walter, Onuma, Oyere, Owolabi, Mayowa, and Sachdev, Sonal
- Subjects
- *
STROKE prevention , *STROKE-related mortality , *AGE distribution , *CORONARY disease , *HYPERTENSION , *MEDICAL protocols , *WORLD health , *DISEASE complications ,STROKE risk factors - Abstract
The authors discuss the risk factors of cerebrovascular accidents and analyzes prevention strategies and guidelines for the management of acute stroke. Topics discussed include the growing incidence of stroke in low and middle-income countries, the unknown factors of younger age onset, and the higher rates of haemorrhagic subtype. Treatment guidelines for patients in low-resource settings, prevention of deep-vein thrombosis, and judicious use of aspirin are also mentioned.
- Published
- 2016
- Full Text
- View/download PDF
3. Sex Difference in Outcomes of Acute Myocardial Infarction in Young Patients.
- Author
-
Sawano, Mitsuaki, Lu, Yuan, Caraballo, César, Mahajan, Shiwani, Dreyer, Rachel, Lichtman, Judith H., D'Onofrio, Gail, Spatz, Erica, Khera, Rohan, Onuma, Oyere, Murugiah, Karthik, Spertus, John A., and Krumholz, Harlan M.
- Subjects
- *
MYOCARDIAL infarction , *YOUNG women - Abstract
Younger women experience worse health status than men after their index episode of acute myocardial infarction (AMI). However, whether women have a higher risk for cardiovascular and noncardiovascular hospitalizations in the year after discharge is unknown. The aim of this study was to determine sex differences in causes and timing of 1-year outcomes after AMI in people aged 18 to 55 years. Data from the VIRGO (Variation in Recovery: Role of Gender on Outcomes of Young AMI Patients) study, which enrolled young patients with AMI across 103 U.S. hospitals, were used. Sex differences in all-cause and cause-specific hospitalizations were compared by calculating incidence rates ([IRs] per 1,000 person-years) and IR ratios with 95% CIs. We then performed sequential modeling to evaluate the sex difference by calculating subdistribution HRs (SHRs) accounting for deaths. Among 2,979 patients, at least 1 hospitalization occurred among 905 patients (30.4%) in the year after discharge. The leading causes of hospitalization were coronary related (IR: 171.8 [95% CI: 153.6-192.2] among women vs 117.8 [95% CI: 97.3-142.6] among men), followed by noncardiac hospitalization (IR: 145.8 [95% CI: 129.2-164.5] among women vs 69.6 [95% CI: 54.5-88.9] among men). Furthermore, a sex difference was present for coronary-related hospitalizations (SHR: 1.33; 95% CI: 1.04-1.70; P = 0.02) and noncardiac hospitalizations (SHR: 1.51; 95% CI: 1.13-2.07; P = 0.01). Young women with AMI experience more adverse outcomes than men in the year after discharge. Coronary-related hospitalizations were most common, but noncardiac hospitalizations showed the most significant sex disparity. [Display omitted] [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
4. Putting polypills into practice: challenges and lessons learned.
- Author
-
Webster, Ruth, Castellano, Jose M., and Onuma, Oyere K.
- Subjects
- *
CARDIOVASCULAR diseases risk factors , *PILLS , *MEDICATION safety , *CLINICAL trials , *PUBLIC health , *CARDIOVASCULAR disease prevention , *ATTITUDE (Psychology) , *CARDIOVASCULAR agents , *COMBINATION drug therapy , *DOSAGE forms of drugs , *FORECASTING , *MEDICAL personnel , *PREVENTIVE health services , *HEALTH insurance reimbursement , *DRUG approval , *LIFESTYLES , *PATIENTS' attitudes , *ESSENTIAL drugs ,DISEASE relapse prevention - Abstract
Regulatory approvals for cardiovascular polypills are increasing rapidly across more than 30 countries. The evidence clearly shows polypills improve adherence and cardiovascular disease risk factors for patients with indications for use of polypill components-ie, those with established cardiovascular disease or at high risk. However, the implementation of polypills into clinical practice has many challenges. The clinical trials literature provides insights into the clinical impact of a polypill strategy, including cost-effectiveness, safety of use, substantial improvement in adherence, and better risk factor control than usual care. Despite the clear need for such a strategy and the available clinical data backing up the use of the polypill in different patient populations, challenges to widespread implementation, such as an absence of government reimbursement and poor physician uptake (identified from on the ground experience in countries following commercial rollout), have greatly obstructed real-world implementation. Obtaining the full public health benefit of polypills will require education, advocacy, endorsement, and implementation by key global agencies such as WHO and national clinical bodies, as well as endorsement from governments. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
5. 2022 ACC Expert Consensus Decision Pathway on Cardiovascular Sequelae of COVID-19 in Adults: Myocarditis and Other Myocardial Involvement, Post-Acute Sequelae of SARS-CoV-2 Infection, and Return to Play: A Report of the American College of Cardiology Solution Set Oversight Committee.
- Author
-
Gluckman, Ty J., Bhave, Nicole M., Allen, Larry A., Chung, Eugene H., Spatz, Erica S., Ammirati, Enrico, Baggish, Aaron L., Bozkurt, Biykem, Cornwell III, William K., Harmon, Kimberly G., Kim, Jonathan H., Lala, Anuradha, Levine, Benjamin D., Martinez, Matthew W., Onuma, Oyere, Phelan, Dermot, Puntmann, Valentina O., Rajpal, Saurabh, Taub, Pam R., and Verma, Amanda K.
- Subjects
- *
POST-acute COVID-19 syndrome , *MYOCARDITIS , *COVID-19 , *DISEASE complications , *ADULTS - Published
- 2022
- Full Text
- View/download PDF
6. Racial/Ethnic Disparities in Aortic Valve Replacement Among Medicare Beneficiaries in the United States, 2012-2019.
- Author
-
Gupta, Aakriti, Mori, Makoto, Wang, Yun, Pawar, Shubhadarshini G., Vahl, Torsten, Nazif, Tamim, Onuma, Oyere, Yong, Celina M., Sharma, Rahul, Kirtane, Ajay J., Forrest, John K., George, Isaac, Kodali, Susheel, Chikwe, Joanna, Geirsson, Arnar, Makkar, Raj, Leon, Martin B., and Krumholz, Harlan M.
- Subjects
- *
AORTIC valve transplantation , *MEDICARE beneficiaries , *HEART valve prosthesis implantation , *ASIANS , *AORTIC stenosis , *RACE - Abstract
There are concerns that transcatheter or surgical aortic valve replacement (TAVR/SAVR) procedures are preferentially available to White patients. Our objective was to examine differences in utilization of aortic valve replacement and outcomes by race/ethnicity in the US for patients with aortic stenosis. We performed a serial cross-sectional cohort study of 299,976 Medicare beneficiaries hospitalized with principal diagnosis of aortic stenosis between 2012 and 2019 stratified by self-reported race/ethnicity (Black, Hispanic, Asian, Native American, and White). Outcomes included aortic valve replacement rates within 6 months of index hospitalization and associated procedural outcomes, including 30-day readmission, 30-day and 1-year mortality. Within 6 months of an index admission for aortic stenosis, 86.8% (122,457 SAVR; 138,026 TAVR) patients underwent aortic valve replacement. Overall, compared with White people, Black (HR 0.87 [0.85-0.89]), Hispanic (0.92 [0.88-0.96]), and Asian (0.95 [0.91-0.99]) people were less likely to receive aortic valve replacement. Among patients who were admitted emergently/urgently, White patients (41.1%, 95% CI, 40.7-41.4) had a significantly higher aortic valve replacement rate compared with Black (29.6%, 95% CI, 28.3-30.9), Hispanic (36.6%, 95% CI, 34.0-39.3), and Asian patients (35.4%, 95% CI, 32.3-38.9). Aortic valve replacement rates increased annually for all race/ethnicities. There were no significant differences in 30-day or 1-year mortality by race/ethnicity. Aortic valve replacement rates within 6 months of aortic stenosis admission are lower for Black, Hispanic, and Asian people compared to White people. These race-related differences in aortic stenosis treatment reflect complex issues in diagnosis and management, warranting a comprehensive reassessment of the entire care spectrum for disadvantaged populations. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
7. Trends in Transcatheter and Surgical Aortic Valve Replacement Among Older Adults in the United States.
- Author
-
Mori, Makoto, Gupta, Aakriti, Wang, Yun, Vahl, Torsten, Nazif, Tamim, Kirtane, Ajay J., George, Isaac, Yong, Celina M., Onuma, Oyere, Kodali, Susheel, Geirsson, Arnar, Leon, Martin B., and Krumholz, Harlan M.
- Subjects
- *
HEART valve prosthesis implantation , *OLDER people , *AORTIC valve transplantation , *PROPORTIONAL hazards models , *TREATMENT effectiveness - Abstract
Background: Recent trends, including survival beyond 30 days, in aortic valve replacement (AVR) following the expansion of indications for transcatheter aortic valve replacement (TAVR) are not well-understood.Objectives: The authors sought to characterize the trends in characteristics and outcomes of patients undergoing AVR.Methods: The authors analyzed Medicare beneficiaries who underwent TAVR and SAVR in 2012 to 2019. They evaluated case volume, demographics, comorbidities, 1-year mortality, and discharge disposition. Cox proportional hazard models were used to assess the annual change in outcomes.Results: Per 100,000 beneficiary-years, AVR increased from 107 to 156, TAVR increased from 19 to 101, whereas SAVR declined from 88 to 54. The median [interquartile range] age remained similar from 77 [71-83] years to 78 [72-84] years for overall AVR, decreased from 84 [79-88] years to 81 [75-86] years for TAVR, and decreased from 76 [71-81] years to 72 [68-77] years for SAVR. For all AVR patients, the prevalence of comorbidities remained relatively stable. The 1-year mortality for all AVR decreased from 11.9% to 9.4%. Annual change in the adjusted odds of 1-year mortality was 0.93 (95% CI: 0.92-0.94) for TAVR and 0.98 (95% CI: 0.97-0.99) for SAVR, and 0.94 (95% CI: 0.93-0.95) for all AVR. Patients discharged to home after AVR increased from 24.2% to 54.7%, primarily driven by increasing home discharge after TAVR.Conclusions: The advent of TAVR has led to about a 60% increase in overall AVR in older adults. Improving outcomes in AVR as a whole following the advent of TAVR with increased access is a reassuring trend. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
8. National Trends and Disparities in Hospitalization for Acute Hypertension Among Medicare Beneficiaries (1999-2019).
- Author
-
Lu, Yuan ScD, Wang, Yun, Spatz, Erica S. MHS, Onuma, Oyere, Nasir, Khurram, Rodriguez, Fatima, Watson, Karol E., Krumholz, Harlan M. SM, Lu, Yuan, Spatz, Erica S, and Krumholz, Harlan M
- Subjects
- *
MEDICARE beneficiaries , *HOSPITAL care , *NOSOLOGY , *HYPERTENSION , *WHITE people - Abstract
Background: In the past 2 decades, hypertension control in the US population has not improved and there are widening disparities. Little is known about progress in reducing hospitalizations for acute hypertension.Methods: We conducted serial cross-sectional analysis of Medicare fee-for-service beneficiaries age 65 years or older between 1999 and 2019 using Medicare denominator and inpatient files. We evaluated trends in national hospitalization rates for acute hypertension overall and by demographic and geographical subgroups. We identified all beneficiaries admitted with a primary discharge diagnosis of acute hypertension on the basis of International Classification of Diseases codes. We then used a mixed effects model with a Poisson link function and state-specific random intercepts, adjusting for age, sex, race and ethnicity, and dual-eligible status, to evaluate trends in hospitalizations.Results: The sample consisted of 397 238 individual Medicare fee-for-service beneficiaries. From 1999 through 2019, the annual hospitalization rates for acute hypertension increased significantly, from 51.5 to 125.9 per 100 000 beneficiary-years; the absolute increase was most pronounced among the following subgroups: adults ≥85 years (66.8-274.1), females (64.9-160.1), Black people (144.4-369.5), and Medicare/Medicaid insured (dual-eligible, 93.1-270.0). Across all subgroups, Black adults had the highest hospitalization rate in 2019, and there was a significant increase in the differences in hospitalizations between Black and White people from 1999 to 2019. Marked geographic variation was also present, with the highest hospitalization rates in the South. Among patients hospitalized for acute hypertension, the observed 30-day and 90-day all-cause mortality rates (95% CI) decreased from 2.6% (2.27-2.83) and 5.6% (5.18-5.99) to 1.7% (1.53-1.80) and 3.7% (3.45-3.84) and 30-day and 90-day all-cause readmission rates decreased from 15.7% (15.1-16.4) and 29.4% (28.6-30.2) to 11.8% (11.5-12.1) and 24.0% (23.5-24.6).Conclusions: Among Medicare fee-for-service beneficiaries age 65 years or older, hospitalization rates for acute hypertension increased substantially and significantly from 1999 to 2019. Black adults had the highest hospitalization rate in 2019 across age, sex, race and ethnicity, and dual-eligible strata. There was significant national variation, with the highest rates generally in the South. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
9. Trends in Differences in Health Status and Health Care Access and Affordability by Race and Ethnicity in the United States, 1999-2018.
- Author
-
Mahajan, Shiwani, Caraballo, César, Lu, Yuan, Valero-Elizondo, Javier, Massey, Daisy, Annapureddy, Amarnath R., Roy, Brita, Riley, Carley, Murugiah, Karthik, Onuma, Oyere, Nunez-Smith, Marcella, Forman, Howard P., Nasir, Khurram, Herrin, Jeph, and Krumholz, Harlan M.
- Subjects
- *
HEALTH & race , *HEALTH services accessibility , *RACIAL differences , *ETHNIC differences , *RACE discrimination in medical care , *HEALTH status indicators , *PUBLIC health , *CROSS-sectional method , *MEDICAL care , *SURVEYS , *INCOME , *COST analysis , *HEALTH equity - Abstract
Importance: The elimination of racial and ethnic differences in health status and health care access is a US goal, but it is unclear whether the country has made progress over the last 2 decades.Objective: To determine 20-year trends in the racial and ethnic differences in self-reported measures of health status and health care access and affordability among adults in the US.Design, Setting, and Participants: Serial cross-sectional study of National Health Interview Survey data, 1999-2018, that included 596 355 adults.Exposures: Self-reported race, ethnicity, and income level.Main Outcomes and Measures: Rates and racial and ethnic differences in self-reported health status and health care access and affordability.Results: The study included 596 355 adults (mean [SE] age, 46.2 [0.07] years, 51.8% [SE, 0.10] women), of whom 4.7% were Asian, 11.8% were Black, 13.8% were Latino/Hispanic, and 69.7% were White. The estimated percentages of people with low income were 28.2%, 46.1%, 51.5%, and 23.9% among Asian, Black, Latino/Hispanic, and White individuals, respectively. Black individuals with low income had the highest estimated prevalence of poor or fair health status (29.1% [95% CI, 26.5%-31.7%] in 1999 and 24.9% [95% CI, 21.8%-28.3%] in 2018), while White individuals with middle and high income had the lowest (6.4% [95% CI, 5.9%-6.8%] in 1999 and 6.3% [95% CI, 5.8%-6.7%] in 2018). Black individuals had a significantly higher estimated prevalence of poor or fair health status than White individuals in 1999, regardless of income strata (P < .001 for the overall and low-income groups; P = .03 for middle and high-income group). From 1999 to 2018, racial and ethnic gaps in poor or fair health status did not change significantly, with or without income stratification, except for a significant decrease in the difference between White and Black individuals with low income (-6.7 percentage points [95% CI, -11.3 to -2.0]; P = .005); the difference in 2018 was no longer statistically significant (P = .13). Black and White individuals had the highest levels of self-reported functional limitations, which increased significantly among all groups over time. There were significant reductions in the racial and ethnic differences in some self-reported measures of health care access, but not affordability, with and without income stratification.Conclusions and Relevance: In a serial cross-sectional survey study of US adults from 1999 to 2018, racial and ethnic differences in self-reported health status, access, and affordability improved in some subgroups, but largely persisted. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
10. Modernizing the World Health Organization List of Essential Medicines for Preventing and Controlling Cardiovascular Diseases.
- Author
-
Kishore, Sandeep P., Blank, Evan, Heller, David J., Patel, Amisha, Peters, Alexander, Price, Matthew, Vidula, Mahesh, Fuster, Valentin, Onuma, Oyere, Huffman, Mark D., and Vedanthan, Rajesh
- Subjects
- *
CARDIOVASCULAR diseases , *DRUGS , *PUBLIC sector , *GUIDELINES - Abstract
The World Health Organization (WHO) Model List of Essential Medicines (EML) is a key tool for improving global access to medicines for all conditions, including cardiovascular diseases (CVDs). The WHO EML is used by member states to determine their national essential medicine lists and policies and to guide procurement of medicines in the public sector. Here, we describe our efforts to modernize the EML for global CVD prevention and control. We review the recent history of applications to add, delete, and change indications for CVD medicines, with the aim of aligning the list with contemporary clinical practice guidelines. We have identified 4 issues that affect decisions for the EML and may strengthen future applications: 1) cost and cost-effectiveness; 2) presence in clinical practice guidelines; 3) feedback loops; and 4) community engagement. We share our lessons to stimulate others in the global CVD community to embark on similar efforts. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
11. SEX DIFFERENCES IN THE HYPERTENSIVE RESPONSE TO EXERCISE PHENOMENON.
- Author
-
Nene, Aishwarya, Agboola, Olayinka J., Herrin, Jeph, Onuma, Oyere, Lu, Yuan, miller, edward james, Spatz, Erica Sarah, and Meadows, Judith Lynne
- Subjects
- *
HYPERTENSION - Published
- 2023
- Full Text
- View/download PDF
12. SEX DIFFERENCE IN CAUSES AND TIMING OF ONE-YEAR OUTCOMES AMONG YOUNG ACUTE MYOCARDIAL INFARCTION PATIENTS; RESULTS FROM THE VIRGO STUDY.
- Author
-
Sawano, Mitsuaki, Lu, Yuan, Caraballo, Cesar, Mahajan, Shiwani, Dreyer, Rachel P., Lichtman, Judith H., D'Onofrio, Gail, Spatz, Erica Sarah, Khera, Rohan, Onuma, Oyere, Murugiah, Karthik, Spertus, John A., and Krumholz, Harlan M.
- Subjects
- *
MYOCARDIAL infarction - Published
- 2023
- Full Text
- View/download PDF
13. Implementing standardized performance indicators to improve hypertension control at both the population and healthcare organization levels.
- Author
-
Campbell, Norm, Ordunez, Pedro, Jaffe, Marc G., Orias, Marcelo, DiPette, Donald J., Patel, Pragna, Khan, Nadia, Onuma, Oyere, and Lackland, Daniel T.
- Abstract
The ability to reliably evaluate the impact of interventions and changes in hypertension prevalence and control is critical if the burden of hypertension-related disease is to be reduced. Previously, a World Hypertension League Expert Committee made recommendations to standardize the reporting of population blood pressure surveys. We have added to those recommendations and also provide modified recommendations from a Pan American Health Organization expert meeting for "performance indicators" to be used to evaluate clinical practices. Core indicators for population surveys are recommended to include: (1) mean systolic blood pressure and (2) mean diastolic blood pressure, and the prevalences of: (3) hypertension, (4) awareness of hypertension, (5) drug-treated hypertension, and (6) drug-treated and controlled hypertension. Core indicators for clinical registries are recommended to include: (1) the prevalence of diagnosed hypertension and (2) the ratio of diagnosed hypertension to that expected by population surveys, and the prevalences of: (3) controlled hypertension, (4) lack of blood pressure measurement within a year in people diagnosed with hypertension, and (5) missed visits by people with hypertension. Definitions and additional indicators are provided. Widespread adoption of standardized population and clinical hypertension performance indicators could represent a major step forward in the effort to control hypertension. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
14. UNEXPLAINED AMYLOID SCREENING AND TREATMENT DROP OFF IN PATIENTS WITH LEFT VENTRICULAR HYPERTROPHY.
- Author
-
Harris, Kristie, Jacoby, Daniel, Singh, Avinainder, Burg, Matthew M., Onuma, Oyere, Kattan, Cesia Gallegos, Shi, Tiantian, and Miller, Edward
- Subjects
- *
LEFT ventricular hypertrophy , *MEDICAL screening , *AMYLOID - Published
- 2022
- Full Text
- View/download PDF
15. Socioeconomic Status Correlates with the Prevalence of Advanced Coronary Artery Disease in the United States.
- Author
-
Bashinskaya, Bronislava, Nahed, Brian V., Walcott, Brian P., Coumans, Jean-Valery C. E., Onuma, Oyere K., and Biondi-Zoccai, Giuseppe
- Subjects
- *
HEALTH outcome assessment , *DISEASE research , *CORONARY disease , *DISEASE prevalence , *CORONARY artery bypass - Abstract
Background: Increasingly studies have identified socioeconomic factors adversely affecting healthcare outcomes for a multitude of diseases. To date, however, there has not been a study correlating socioeconomic details from nationwide databases on the prevalence of advanced coronary artery disease. We seek to identify whether socioeconomic factors contribute to advanced coronary artery disease prevalence in the United States. Methods and Findings: State specific prevalence data was queried form the United States Nationwide Inpatient Sample for 2009. Patients undergoing percutaneous coronary angioplasty and coronary artery bypass graft were identified as principal procedures. Non-cardiac related procedures, lung lobectomy and hip replacement (partial and total) were identified and used as control groups. Information regarding prevalence was then merged with data from the Behavioral Risk Factor Surveillance System, the largest, on-going telephone health survey system tracking health conditions and risk behaviors in the United States. Pearson's correlation coefficient was calculated for individual socioeconomic variables including employment status, level of education, and household income. Household income and education level were inversely correlated with the prevalence of percutaneous coronary angioplasty (-0.717; -0.787) and coronary artery bypass graft surgery (-0.541; -0.618). This phenomenon was not seen in the non-cardiac procedure control groups. In multiple linear regression analysis, socioeconomic factors were significant predictors of coronary artery bypass graft and percutaneous transluminal coronary angioplasty (p<0.001 and p = 0.005, respectively). Conclusions: Socioeconomic status is related to the prevalence of advanced coronary artery disease as measured by the prevalence of percutaneous coronary angioplasty and coronary artery bypass graft surgery. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.